“…The findings of Nazzari et al, 12 however, reiterate that TAVR is not a panacea, and that unfortunately a subset of patients who experience multiple rehospitalizations remains. As geriatric cardiology emerges as a discipline, 17 and as patientengagement in trials gains further momentum, we need to capitalize on these opportunities to expand the integration of truly patient-oriented metrics for the identification of "meaningful" procedural success.…”